<DOC>
	<DOCNO>NCT00692016</DOCNO>
	<brief_summary>The purpose study provide information well extend release formulation ( medication release absorbed long period time regular release formulation medication ) naproxen sodium absorb bloodstream eat high calorie breakfast also fast ( eat 14 hour ) .</brief_summary>
	<brief_title>Fast &amp; Fed Pharmacokinetic ( PK ) Study</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy , ambulatory , male female volunteer 18 55 year age Body Mass Index ( BMI ) approximately 18 30 kg/m2 , total body weight &gt; 50 kg ( 110 lb ) ; Results screen clinical laboratory test within normal range consider clinically significant Principal Investigator Sponsor ; Female subject childbearing potential must use medically acceptable form birth control least 1 month prior screen ( 3 month oral contraceptive ) , e.g. , oral patch contraceptive , intrauterine device , NuvaRing® , DepoProvera® , doublebarrier negative pregnancy test Screening Day 0 dose period . Female subject nonchildbearing potential must amenorrheic least 2 year hysterectomy and/or bilateral oophorectomy History hypersensitivity aspirin ( ASA ) , naproxen sodium , acetaminophen , similar pharmacological agent component product ; Females pregnant lactate ; Loss blood excess 500 ml within 56 day first dose trial treatment ( e.g. , donation , plasmapheresis injury ) ; History gastrointestinal bleeding perforation , relate previous NSAID therapy . Active , history recurrent peptic ulcer/hemorrhage ( two distinct episode proven ulceration bleeding ) ; Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic disease malignancy ; Positive alcohol drug test ; Have take medication ( except acceptable form birth control ) within 10 day prior dose throughout study , unless opinion Investigator Sponsor , medication interfere study procedure , data integrity , compromise safety subject ; Have take ASA , ASAcontaining product , acetaminophen ( acetylparaaminophenol APAP ) NSAID ( OTC prescription ) 7 day prior dose treatment period , study treatment ; Smokers currently consume type tobacco product ( ) include smoke cessation nicotinecontaining product ( e.g. , nicotine patch , nicotine gum ) ; Have take vitamin herbal supplement within 7 day prior dose refuse refrain use study ; Alcoholism drug abuse within 2 year prior Screening Visit ; Participation trial involve investigational market product within 30 day prior Screening Visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Naproxen Sodium</keyword>
</DOC>